Go To
Clinical Practice Guidelines - Breast Cancer Risk Reduction Guideline Update:
The Journal of Clinical Oncology (JCO) recently published ASCO’s Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction.
Family of Websites - ASCO University™ Provides Interactive, Social Learning for Oncology Professionals: Jamie Von Roenn, MD, discusses how ASCO University™ provides users with a diverse collection of content and supporting resources.
NCI Program Highlights - Putting Minds and Words Together: The NCI, C-Change Cooperative Effort in Communication: C-Change, including NCI, ASCO, and other national cancer leaders, has worked to unite the entire cancer community around a core set of consumer-tested messages related to reducing people’s risk for cancer.
Spotlight on State Affiliates - West Virginia Oncology Society: John Azar, MD, discusses the activities of the West Virginia Oncology Society.
Tribute - ASCO Remembers William A. Knight III, MD : William A. Knight III, MD, a respected cancer researcher and dedicated practicing oncologist, died on May 16, 2009.
